Newly Listed Harmonized Standards
Newly Listed Harmonized Standards
Regulatory Affairs In Vitro Diagnostics
Monday, 14 October 2024
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
On October 9th, 2024, Commission Implementing Decisions (EU) 2024/2625 and (EU) 2024/2631 were published in the Official Journal of the European Union, adopting two new harmonized standards under Regulation (EU) 2017/746 (IVDR) and one under Regulation (EU) 2017/745 (MDR).
Play
Newly Listed Harmonized Standards | QbD Group Regulatory Update
AI-generated audio
1:12
EN ISO 13408-1:2024 Aseptic processing of health care products – Part 1: General requirements (ISO 13408-1:2023) is now a harmonised standard under both the MDR and the IVDR, whereas EN ISO 20916:2024 In vitro diagnostic medical devices – Clinical performance studies using specimens from human subjects – Good study practice (ISO 20916:2019) is now a harmonised standard under the IVDR.
Commission Implementing Decision (EU) 2024/2625 amending Implementing Decision (EU) 2021/1195
Commission Implementing Decision (EU) 2024/2631 amending Implementing Decision (EU) 2021/1182
What does it mean to you?
Compliance with standards ISO 13408-1:2023 or ISO 20916:2019, while not mandatory, now confers a presumption of conformity with the corresponding requirements set out in either the MDR or the IVDR.
Get in touch with our experts
Should you want to discuss this more in-depth with one of our consultants, please do not hesitate to contact us.
Discover more expert content
Previous
Regulatory Affairs
1 Oct 2024
Revised MDCG 2021-4 Guidance Documents Released
Regulatory Affairs
6 Feb 2025
PMS Statutory Instrument + MHRA Guidance released (Great Britain)
The Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance to assist...
Regulatory Affairs
11 Jul 2024
Publication of Amendments to Regulation (EU) 2024/1860
Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...
Regulatory Affairs
14 Mar 2024
Newly Published Harmonized Standards for MDR and IVDR Compliance
On March 8th, 2024, “Commission Implementing Decision (EU) 2024/815 of March 6th, 2024 amending...
Regulatory Affairs
26 Nov 2024
New Q&A released on the gradual roll-out of EUDAMED
On November 21st, 2024, the Medical Device Coordination Group (MDCG) released a Q&A on the gradual...
Regulatory Affairs
1 Oct 2024
Revised MDCG 2021-4 Guidance Documents Released
Regulatory Affairs
6 Feb 2025
PMS Statutory Instrument + MHRA Guidance released (Great Britain)
The Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance to assist...
Regulatory Affairs
11 Jul 2024
Publication of Amendments to Regulation (EU) 2024/1860
Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...
Regulatory Affairs
14 Mar 2024
Newly Published Harmonized Standards for MDR and IVDR Compliance
On March 8th, 2024, “Commission Implementing Decision (EU) 2024/815 of March 6th, 2024 amending...
Regulatory Affairs
26 Nov 2024
New Q&A released on the gradual roll-out of EUDAMED
On November 21st, 2024, the Medical Device Coordination Group (MDCG) released a Q&A on the gradual...
Regulatory Affairs
1 Oct 2024
Revised MDCG 2021-4 Guidance Documents Released
Regulatory Affairs
6 Feb 2025
PMS Statutory Instrument + MHRA Guidance released (Great Britain)
The Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance to assist...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe